Nonadherence likely owed to mix of side effects such as nausea and vomiting and out-of-pocket costs

Risk reduced for 10 of 13 obesity-associated cancers with GLP-1 RA use versus insulin in individuals with type 2 diabetes

Estradiol associated with reduced metabolic syndrome risk and testosterone associated with increased risk in both cisgender, transgender individuals

Significant risk reduction for death and vascular complications seen with maintaining at least four years of nondiabetes

Reduction seen in cardiovascular events irrespective of baseline HbA1c or change in HbA1c

Patients with overweight, obesity receiving tirzepatide significantly more likely to achieve ≥5, ≥10, and ≥15 percent weight loss

By Beth Gilbert HealthDay ReporterThe annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested in diabetes. The conference highlighted the latest advances …

24.9 percent received creatinine and UACR screening; Hispanic ethnicity associated with lack of screening

Significant decrease seen in peripheral insulin sensitivity with four-day energy balance diet plus oral BPA administration

Authors say inhaled insulin may provide convenient alternative delivery method